Bayesian Capital Management’s International Flavors & Fragrances IFF Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2025
Q4
Sell
-19,861
Closed -$1.22M 321
2025
Q3
$1.22M Buy
+19,861
New +$1.36M 0.25% 124
2025
Q1
Sell
-19,761
Closed -$1.67M 773
2024
Q4
$1.67M Sell
19,761
-12,200
-38% -$1.15M 0.2% 148
2024
Q3
$3.35M Buy
31,961
+11,700
+58% +$1.17M 0.39% 57
2024
Q2
$1.93M Buy
+20,261
New +$1.86M 0.22% 119
2024
Q1
Sell
-115,061
Closed -$9.32M 934
2023
Q4
$9.32M Buy
+115,061
New +$8.32M 0.99% 11
2022
Q3
Sell
-3,200
Closed -$381K 850
2022
Q2
$381K Buy
+3,200
New +$400K 0.07% 403
2021
Q1
Sell
-10,400
Closed -$1.13M 607
2020
Q4
$1.13M Buy
+10,400
New +$1.17M 0.3% 87
2018
Q1
Sell
-5,400
Closed -$824K 699
2017
Q4
$824K Buy
+5,400
New +$811K 0.17% 208
2017
Q2
Sell
-10,500
Closed -$1.39M 514
2017
Q1
$1.39M Buy
+10,500
New +$1.29M 0.66% 17
2016
Q4
Sell
-2,663
Closed -$381K 645
2016
Q3
$381K Buy
+2,663
New +$361K 0.25% 145

Other funds holding IFF

Bayesian Capital Management's IFF Position: Q4 2025 in Review

Bayesian Capital Management sold out of International Flavors & Fragrances (IFF) in Q4 2025, closing a stake of 19,861 shares — an estimated $1.22M sold.

Bayesian Capital Management first reported a position in IFF in Q3 2016 and held it in 10 quarters. The position peaked at $9.32M in Q4 2023. 707 funds tracked by Wall St. Rank hold IFF as of Q4 2025.

  • Bayesian Capital Management reported no remaining International Flavors & Fragrances position as of Q4 2025 after selling out during the quarter.
  • Bayesian Capital Management sold 19,861 International Flavors & Fragrances shares in Q4 2025, an estimated $1.22M.
  • Bayesian Capital Management first reported a position in International Flavors & Fragrances in Q3 2016 and held it in 10 quarters.
  • Bayesian Capital Management's International Flavors & Fragrances position peaked at $9.32M in Q4 2023.
  • 707 funds tracked by Wall St. Rank held International Flavors & Fragrances as of Q4 2025.

Based on Bayesian Capital Management's 13F filing for Q4 2025, filed 17 Feb 2026.